* Nephros Inc NEPH.OQ NEPH.O is expected to show a rise in
quarterly revenue when it reports results on August 5.
* The South Orange, New Jersey-based company is expected to
report a 50.7% increase in revenue to $2.376 million from
$1.58 million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Nephros Inc is for a
loss of 11 cents per share. For the same quarter last year, the
company reported a loss of 19 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Nephros Inc is
$13, about 31.5% above its last closing price of $8.90.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.12 -0.12 -0.11 Beat 7.6
Dec. 31 2020 -0.12 -0.11 -0.08 Beat 27.3
Sep. 30 2020 -0.14 -0.14 -0.12 Beat 12.2
Jun. 30 2020 -0.15 -0.15 -0.19 Missed -26.7
Mar. -0.08 -0.08 -0.13 Missed -62.5
31 2020
Dec. 31 2019 -0.11 -0.11 -0.02 Beat 82.4
Sep. 30 2019 -0.10 -0.10 -0.10 Met -3.4
Jun. 30 2019 -0.18 -0.18 -0.14 Beat 22.2
This summary was machine generated August 4 at 01:41 GMT. All
figures in US dollars unless otherwise stated